Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: A phase I-II clinical study

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 2093-2096

  Fiorentini, Giammaria ^a   Rossi, Susanna ^a   Dentico, Patrizia ^a   Meucci, Francesco ^a   Bonechi, Francesco ^a   Bernardeschi, Paolo ^a   Cantore, Maurizio ^b   Guadagni, Stefano ^c   De Simone, Michele ^a  

^a SAN GIUSEPPE HOSPITAL   (Italy)

^b Department of Oncology   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Hepatic arterial infusion chemotherapy; Liver metastases from colorectal cancer; Oxaliplatin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MORPHINE; OXALIPLATIN; PLASMA SUBSTITUTE; RANITIDINE; SEROTONIN 3 ANTAGONIST; WARFARIN;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTERY OCCLUSION; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE SEVERITY; DOSE RESPONSE; DRUG INFUSION; DRUG RESEARCH; FEMALE; HEPATIC ARTERY; HUMAN; HYPOTENSION; LIVER METASTASIS; MALE; NAUSEA; NEUROPATHY; OUTPATIENT CARE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT FAILURE; WEIGHT GAIN;

AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS;

EID: 3242679883     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lorenz M and Muller HH: Randomised, multicentre trial of fluorouracil administered either via hepatic arterial or intravenous infusion versus fuorodeoxyuridine administered via hepatic arterial infusion in patients with non resectable liver metastases from colorectal carcinoma. J Clin Oncol 18: 243-254, 2000.
2. Tono T, Hasuike Y, Orzato H et al: Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomised study. Cancer 88: 1549-1556, 2000.
3. Kemeny N, Huang Y, Cohen AM et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341: 2039-2048, 1999.
4. O'Connell MJ, Nagorney DM, Bernath AM et al: Sequential intrahepatic and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 16: 2528-2533, 1998.
5. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J Natl Cancer Inst 88: 252-258, 1996.
6. Fiorentini G, Poddie DB, De Giorgi U et al: Global approach to hepatic metastases from colorectal cancer: indications and outcome of intra-arterial chemotherapy and other hepatic directed treatments. Med Oncol 17: 163-173, 2000.
7. Haller DG: Waiting for the definitive trial of hepatic arterial chemotherapy for colorectal cancer. J Clin Oncol 18: 239-242, 2000.
8. Fiorentini G, De Giorgi U, Giovanis P et al: Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: need of guidelines for catheter positioning, port management, and anti-coagulant therapy. Ann Oncol 12(7): 1023, 2001.
9. Fiorentini G, Poddie DB, Cantore M et al: Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intra-arterial chemotherapy, and new hepatic-directed modalities. Hepatogastroenterology 48(38): 305-312, 2001.
10. Fiorentini G, Ricci Lucchi S, Giovanis P et al: Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: results of a phase I clinical study. Tumori 87: 388-390, 2001.
11. Kouroussis C, Souglakos J, Mavroudis D et al: Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer. Am J Clin Oncol 25(6): 627-631, 2002.
12. Comella P, Casaretti R, De Rosa V et al: Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal maligniancies. Ann Oncol 13(12): 1874-1881, 2002.
13. Cunningham D, Pyrhonen S, James RD et al: Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352: 1413-1418, 1998.
14. Fishman AD and Wadler S: Advances in the treatment of metastatic colorectal cancer. Clin Colorectal Cancer 1(1): 20-35, 2001.
15. Schmoll HJ: The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions. Semin Oncol 29(5 Suppl 15): 34-39, 2002.
16. Kern W, Beckert B, Lang N et al: Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Onc 12: 599-603, 2001.
17. Cassidy J and Misset JI: Oxaliplatin-related side effects: characteristic and management. Semin Oncol 29(5 Suppl 15): 11-20, 2002.
18. Eisenhauer EA, O'Dwyer PJ, Christian M and Humphrey JS: Phase I clinical trial design in cancer drug development. J Clin Oncol 18: 684-692, 2000.
19. World Health Organization: Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication N° 38. Geneva: WHO 1979.
20. Curley SA and Vecchio R: New trends in the surgical treatment of colorectal cancer liver metastases. Tumori 84: 281-288, 1998.
21. Fong Y, Cohen AM, Fortner JG et al: Liver resection for colorectal metastases. J Clin Oncol 15: 938-946, 1997.
22. Becouarn Y, Ychou M, Ducrex M et al: Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol 16: 2739-2744, 1998.
23. Thirion P, Wolmark N, Haddad E et al: Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: A re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer. Ann Oncol 10: 1317-1320, 1999.
24. Kern W, Baess J, Bottger B et al: Oxaliplatin pharmacokinetics during a four-hour infusion. Clin Cancer Res 5: 761-765, 1999.